Serum miR-9 as a prognostic biomarker in patients with osteosarcoma

Journal of International Medical Research

Volumn 42, Issue 4, 2014, Pages 932-937

  Fei, Dan ^a   Li, Yang ^a   Zhao, Dongxu ^a   Zhao, Kaijun ^a   Dai, Lu ^a   Gao, Zhongli ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

MicroRNA 9; osteosarcoma; serum

Indexed keywords

MICRORNA 9; GENETIC MARKER; MICRORNA; MIRN92 MICRORNA, HUMAN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC ASSOCIATION; HUMAN; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UPREGULATION; BLOOD; GENETIC MARKER; GENETICS; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84904654850     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514534643     Document Type: Article

References (29)

1. Geller DS,Gorlick R.Osteosarcoma: a review of diagnosis, management, and treatment strategies.Clin Adv Hematol Oncol. 2010;8:705-718.
2. Gorlick R.Current concepts on the molecular biology of osteosarcoma.Cancer Treat Res. 2009;152:467-478.
3. Ta HT,Dass CR,Choong PF,et al.Osteosarcoma treatment: state of the art.Cancer Metastasis Rev. 2009;28:247-263.
4. Ambros V.The functions of animal microRNAs.Nature. 2004;431:350-355.
5. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004;116:281-297.
6. Zamore PD,Haley B.Ribo-gnome: the big world of small RNAs.Science. 2005;309:1519-1524.
7. Xu Z,Wang T.MiR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.Biochem Biophys Res Commun. 2014;449:190-195.
8. Lewis BP,Burge CB,Bartel DP.Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.Cell. 2005;120:15-20.
9. Cho WC.OncomiRs: the discovery and progress of microRNAs in cancers.Mol Cancer. 2007;6:60-60.
10. Tang M,Lin L,Cai H,et al.MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma.Onco Targets Ther. 2013;6:833-838.
11. Guo F,Tian J,Lin Y,et al.Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.J Int Med Res. 2013;41:1456-1461.
12. Mitchell PS,Parkin RK,Kroh EM,et al.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci U S A. 2008;105:10513-10518.
13. Li ZH,Zhang H,Yang ZG,et al.Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.J Int Med Res. 2013;41:1437-1444.
14. Zhu L,Chen H,Zhou D,et al.MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.Med Oncol. 2012;29:1037-1043.
15. Ma L,Young J,Prabhala H,et al.miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.Nat Cell Biol. 2010;12:247-256.
16. Xu T,Liu X,Han L,et al.Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.Clin Transl Oncol. 2014;16:469-475.
17. Tio TL.The TNM staging system.Gastrointest Endosc. 1996;43 (Pt 2): S19-S24.
18. Lawrie CH,Gal S,Dunlop HM,et al.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.Br J Haematol. 2008;141:672-675.
19. Leucht C,Stigloher C,Wizenmann A,et al.MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary.Nat Neurosci. 2008;11:641-648.
20. Li Y,Wang F,Lee JA,et al.MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila.Genes Dev. 2006;20:2793-2805.
21. Shibata M,Kurokawa D,Nakao H,et al.MicroRNA-9 modulates Cajal-Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium.J Neurosci. 2008;28:10415-10421.
22. Wilting SM,Snijders PJ,Verlaat W,et al.Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.Oncogene. 2013;32:106-116.
23. Omura N,Li CP,Li A,et al.Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.Cancer Biol Ther. 2008;7:1146-1156.
24. Laios A,O'Toole S,Flavin R,et al.Potential role of miR-9 and miR-223 in recurrent ovarian cancer.Mol Cancer. 2008;7:35-35.
25. Bandres E,Agirre X,Bitarte N,et al.Epigenetic regulation of microRNA expression in colorectal cancer.Int J Cancer. 2009;125:2737-2743.
26. Zhang H,Qi M,Li S,et al.microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.Mol Cancer Ther. 2009;11:1454-1466.
27. Ferretti E,De Smaele E,Po A,et al.MicroRNA profiling in human medulloblastoma.Int J Cancer. 2009;124:568-577.
28. Guo LM,Pu Y,Han Z,et al.MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.FEBS J. 2009;276:5537-5546.
29. Namløs HM,Meza-Zepeda LA,Barøy T,et al.Modulation of the osteosarcoma expression phenotype by microRNAs.PLoS One. 2012;7:e48086-e48086.